Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114653) titled 'The Role of POLE Mutation in High Risk Endometrial Cancer' on Aug. 4.
Study Type: Observational
Primary Sponsor: Far Eastern Memorial Hospital
Condition:
Endometrial Neoplasms
Recruitment Status: Recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 150
Countries of Recruitment:
Taiwan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114653
Published by HT Digital Content Services with permission from Health Daily Digest....